Evidence map›Paper›PMID 36291693›Full record

ArticleBiomolecules2022

Effects of Atomoxetine on Motor and Cognitive Behaviors and Brain Electrophysiological Activity of Dopamine Transporter Knockout Rats.

Maria Ptukha, Zoia Fesenko, Anastasia Belskaya, Arina Gromova, Arseniy Pelevin, Natalia Kurzina, Raul R Gainetdinov, Anna Volnova

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Maria PtukhaInstitute of Translational Biomedicine, Saint Petersburg State University, 199034 Saint Petersburg, Russia.
Zoia FesenkoInstitute of Translational Biomedicine, Saint Petersburg State University, 199034 Saint Petersburg, Russia.
Anastasia BelskayaInstitute of Translational Biomedicine, Saint Petersburg State University, 199034 Saint Petersburg, Russia.
Arina GromovaFaculty of Biology, Saint Petersburg State University, 199034 Saint Petersburg, Russia.
Arseniy PelevinFaculty of Biology, Saint Petersburg State University, 199034 Saint Petersburg, Russia.
Natalia KurzinaInstitute of Translational Biomedicine, Saint Petersburg State University, 199034 Saint Petersburg, Russia.
Raul R GainetdinovInstitute of Translational Biomedicine, Saint Petersburg State University, 199034 Saint Petersburg, Russia.
Anna VolnovaInstitute of Translational Biomedicine, Saint Petersburg State University, 199034 Saint Petersburg, Russia.ORCID 0000-0003-0724-887X
St Petersburg University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Changes in dopaminergic and noradrenergic transmission are considered to be the underlying cause of attention deficit and hyperactivity disorder (ADHD). Atomoxetine (ATX) is a selective norepinephrine transporter (NET) inhibitor that is currently used for ADHD treatment. In this study, we aimed to evaluate the effect of atomoxetine on the behavior and brain activity of dopamine transporter knockout (DAT-KO) rats, which are characterized by an ADHD-like behavioral phenotype. Prepulse inhibition (PPI) was assessed in DAT-KO and wild type rats after saline and ATX injections, as well as behavioral parameters in the Hebb-Williams maze and power spectra and coherence of electrophysiological activity. DAT-KO rats demonstrated a pronounced behavioral and electrophysiological phenotype, characterized by hyperactivity, increased number of errors in the maze, repetitive behaviors and disrupted PPI, changes in cortical and striatal power spectra and interareal coherence. Atomoxetine significantly improved PPI and decreased repetitive behaviors in DAT-KO rats and influenced behavior of wild-type rats. ATX also led to significant changes in power spectra and coherence of DAT-KO and wild type rats. Assessment of noradrenergic modulation effects in DAT-KO provides insight into the intricate interplay of monoaminergic systems, although further research is still required to fully understand the complexity of this interaction.

Indexed as

Dopamine Plasma Membrane Transport ProteinsNorepinephrine Plasma Membrane Transport ProteinsAnimalsAtomoxetine HydrochlorideCognitionCorpus StriatumNorepinephrineRatsAtomoxetine HydrochlorideDopamine Plasma Membrane Transport ProteinsNorepinephrineNorepinephrine Plasma Membrane Transport ProteinsADHDatomoxetinecoherencedopaminedopamine transporter knockout (DAT-KO) ratsnorepinephrine transporter (NET)power spectraprepulse inhibition

Identifiers

PMID36291693
PMCPMC9599468
OpenAlexW4306362454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.